About
Our research focuses on the health issues of blindness, cancer and drug abuse, which have huge socioeconomic implications.
Our lab applies engineering principles to advance our understanding of the interactions of therapeutic nanoparticle platforms with biological barriers and disease pathophysiology. This knowledge guides us to better design new biomaterials and nanotherapeutic-based treatments for eye disorders, cancer and other diseases.
Our research program operates at the interface of nanoengineering, materials science and translational medicine. We aim to translate technologies to have a meaningful impact on human health.
News
Congratulations to Ehsan Kaffash for passing his Ph.D. candidacy exam. Ehsan works on the ocular drug delivery systems.
Congratulations to Surendra Poudel for passing his Ph.D. candidacy exam. Surendra works on the reverse engineering of in-situ forming implant.
Drs. Marina Gorbatyuk (contact PI) and Maria Grant at University of Alabama at Birmingham and Dr. Xu received a 4-year NIH/NEI R01 "RXR-based therapy for diabetic retinopathy." Dr. Xu serves as a co-PI.